about
Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motilityBevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries.BLCA1 expression is associated with angiogenesis of bladder cancer and is correlated with common pro-angiogenic factors.Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation.Molecular signature of anastasis for reversal of apoptosis.Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.Structural and functional identification of vasculogenic mimicry in vitro.Novel TIE-2 inhibitor BAY-826 displays in vivo efficacy in experimental syngeneic murine glioma models.Utilizing Zebrafish to Identify Anti-(Lymph)Angiogenic Compounds for Cancer Treatment: Promise and Future Challenges.Roles of RUNX in Hypoxia-Induced Responses and Angiogenesis.HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma.Tumor radiosensitization by gene therapy against endoglin.Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents.G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response.In silico prediction of targets for anti-angiogenesis and their in vitro evaluation confirm the involvement of SOD3 in angiogenesis.Angiogenic Properties of 'Leukocyte- and Platelet-Rich Fibrin'
P2860
Q28820722-539FAC92-567E-4BA4-89DF-A40B079346C8Q33859790-B7FCF867-3D3F-4C41-897F-7C5F1D1A55DFQ36317920-E57F7EE8-47C7-421C-963C-D20F34F83BCFQ36954000-43C9BE00-2892-409D-808C-FF8B418F2468Q37643379-666B5394-696D-4886-8A87-788262D7BC04Q37696220-3804F6C3-6572-4892-86BD-C4A0AB68FE8FQ38648314-D5BA1C1C-B74A-4651-AE71-9F7C665308C5Q38736319-033F13C2-B88D-4D9F-B073-7EA22EB02353Q38833891-135F55D8-0B38-4578-AE56-A2C78A687C8FQ39181432-192A150A-4ED6-4116-BC08-9222CACC81A5Q41472694-512F689F-7375-4D3E-811A-57D1668462C1Q45886138-F5885100-938A-453D-B618-2C4B18F88652Q47136066-B15AEEBB-01B5-4E7A-BA87-21CB7ED288DBQ47174627-25ED8B53-F1ED-47CE-A11D-3499772EDCDBQ49283462-C650124C-2C90-40EB-8238-01127ADC10A7Q50204216-174B8C66-A59B-46EC-9310-05B068DCA9F9Q55019812-0DE41107-35C4-47AD-BB31-FFAF1B4426E2Q57050421-A1B9DD28-AD52-440E-B2AA-52B1B791A416
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Compensatory angiogenesis and tumor refractoriness
@ast
Compensatory angiogenesis and tumor refractoriness
@en
Compensatory angiogenesis and tumor refractoriness
@nl
type
label
Compensatory angiogenesis and tumor refractoriness
@ast
Compensatory angiogenesis and tumor refractoriness
@en
Compensatory angiogenesis and tumor refractoriness
@nl
prefLabel
Compensatory angiogenesis and tumor refractoriness
@ast
Compensatory angiogenesis and tumor refractoriness
@en
Compensatory angiogenesis and tumor refractoriness
@nl
P2860
P356
P1433
P1476
Compensatory angiogenesis and tumor refractoriness
@en
P2093
R N Gacche
P2860
P2888
P356
10.1038/ONCSIS.2015.14
P407
P577
2015-06-01T00:00:00Z
P6179
1044906581